#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary haemorrhagic telangiectasia Diffuse large B-cell lymphoma Advanced systemic mastocytosis Crohn's disease Marginal zone lymphoma Henoch-Schonlein purpura Neuroendocrine carcinoma of the skin Friedreich's ataxia Retinopathy of prematurity Arterial tortuosity syndrome Mucous membrane pemphigoid Peritoneal mesothelioma malignant Hepatitis D Gastroenteropancreatic neuroendocrine tumour disease Colon cancer More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia Gaucher’s disease type III – Life with Disease Hairy cell leukaemia – Basic Information Isodicentric chromosome 15 syndrome – Diagnostics Congenital generalised lipodystrophy Mitochondrial myopathy – Basic Information Adrenogenital syndrome – Diagnostics Angiosarcoma recurrent – Diagnostics Alternating hemiplegia of childhood – Basic Information Inclusion body myositis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elenestinib Phosphate ALFENTANIL HYDROCHLORIDE Concizumab Ro7269162 Art6043 Ziclumeran Golcadomide Evg321 Avacopan Loperamide XMAB942 Remimazolam Tucatinib Ecoo75 Ferumoxytol Albiglutide Zenocutuzumab Siponimod Quemliclustat Tofacitinib More therapies…

    Learn about Your Condition

    Subarachnoid haemorrhage Dry eye Bronchiolitis Hepato-lenticular degeneration Nasopharyngeal cancer Rectosigmoid cancer Dyslipidaemia Death neonatal Radiation skin injury Vulval cancer recurrent Eclampsia Immune system disorder Breast angiosarcoma metastatic Stevens-Johnson syndrome Polycystic ovarian syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Drug dependence

  • Study of semaglutide to reduce cannabis use in adults with cannabis use disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Semaglutide
    • Sodium Chloride
    Denmark

  • Study on Sustained-Release Dexamphetamine and Piracetam for Patients with Moderate to Severe Cocaine Use Disorder and Opioid Dependence

    Recruiting

    3 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Dexamfetamine Sulfate
    • Piracetam
    The Netherlands

  • Study on Baclofen for Reducing Benzodiazepine Use in Patients with Benzodiazepine Dependence

    Recruiting

    4 1 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Azelastine Hydrochloride
    • Baclofen
    • Zopiclone
    France

  • Study of diazepam and oxazepam in patients with benzodiazepine and opioid dependence who are receiving opioid agonist therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Oxazepam
    • Diazepam
    Norway

  • A study of psilocybin and psychological support compared to diphenhydramine hydrochloride for people with cocaine addiction

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Diphenhydramine Hydrochloride
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Ireland

  • Study on How N-acetylcysteine Helps Treat Cannabis Addiction in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Acetylcysteine
    Belgium
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!